Fast Company January 3, 2022
Ruth Reader

Telehealth took off during the pandemic, but 2021 was a brutal awakening. The healthcare industry is still figuring out how it fits into the big picture.

When the U.S. raced to lock down the country in the face of a quickly spreading novel disease, telehealth provided a lifeline. Using technology such as video calls, healthcare organizations were able to screen individuals for COVID-19 before there was any testing infrastructure. But now in this later stage of the pandemic, Americans are coming out of their homes and going back to the doctor’s office. Stocks for big telehealth companies are down.

While telehealth remains an important tool for doctors, it no longer seems likely—as online pharmacy Hims CEO Andrew Dudam once posited—that...

Today's Sponsors

Patient Bond
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

Topics: Digital Health, Health IT, Patient / Consumer, Provider, Technology, Telehealth
Venture capital firm launches $75M telehealth-focused fund
URAC CEO talks virtual care access, tele-mental health, post-COVID regs
Telemedicine 2022
Telehealth use after pandemic is uncertain, study finds
Sustainable healthcare delivery: a case for telemedicine